Dan G. Duda, DMD, PhD, of the Edwin L. Steele Laboratories for Tumor Biology and Department of Radiation Oncology at Massachusetts General Hospital, is the corresponding author of a paper published in Cancer Immunology Research, “Combination CXCR4 and PD1 Blockade Enhances Intratumoral Dendritic Cell Activation and Immune Responses Against Hepatocellular Carcinoma.”
Discover how a new rapid test developed at Mass General Brigham is enabling doctors to diagnose brain tumors faster, including Rohan’s high-grade glioma.
Discover how proton radiation therapy saved the life of 19-year-old Chris Kobos after he was diagnosed with a rare chordoma. Read his patient story.
Newly defined strategy will extend the frontier for research-driven excellence in cancer care across all patients and across all communities.
These drugs (bevacizumab and losartan) alone and in combination with anti-microbial agents, promoted anti-bacterial host responses and improved health outcomes in lab models with tuberculosis.
Researchers developed a two-part approach to increasing levels of cell-free DNA in the blood to improve the sensitivity of liquid biopsies.
Sophia C. Kamran, MD, a physician investigator in the Mass General Cancer Center and an assistant professor of Radiation Oncology at Harvard Medical School, is the first author of a recently published paper in Clinical Cancer Research, Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer.
Among both men and women, non-smokers and smokers, lung cancer remains the leading cause of cancer-related death. n recognition of Lung Cancer Awareness Month, Massachusetts General Hospital physicians answer common questions related to lung cancer.
In multi-year study, Mass General Cancer Center researchers found increase in rates for liver cancer deaths among Hispanic men and rates for liver, pancreatic, and uterine cancer deaths among Hispanic women.
A colon cancer diagnosis was no match for airline pilot and member of the Air National Guard, Rick Mastalerz. Read Rick and Sally’s patient story here.
The Massachusetts General Hospital Department of Radiation Oncology is a leader in developing and implementing some of the most innovative and effective radiation therapies in the world.
